KEY PRODUCTS
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
01 1Seqens
01 1CETIRIZINE DIHYDROCHLORIDE
01 1France
01 1Active
01 1Complete
Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
GDUFA
DMF Review : Complete
Rev. Date : 2017-03-03
Pay. Date : 2017-02-08
DMF Number : 16244
Submission : 2002-11-14
Status : Active
Type : II
20
Wavelength Enterprises Ltd, based in France, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.
One of their notable products is CETIRIZINE DIHYDROCHLORIDE, with a corresponding US DMF Number 16244.
Remarkably, this DMF maintains an Active status since its submission on November 14, 2002, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of March 03, 2017, and payment made on February 08, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II
